EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico investigations revealed four potential colon cancer drugs from phytochemicals in Zingiber officinale

Fortunatus Chidolue Ezebuo, Colin B Lukong, Ikemefuna C Uzochukwu, Irene N Okafor

International Journal of Phytomedicine · 2016

DOI: 10.5138/09750185.1886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Phytomedicine, 2016. Verfasst von Fortunatus Chidolue Ezebuo und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a difficult disease to treat, and few effective drugs are available. Hence, it is of great importance to develop effective anti-cancer therapeutic agents with well-defined pharmacokinetic properties. Although, ginger (Zingiber officinale) has a number of proven pharmacological activities, its effect on colon cancer has not received much attention. This study therefore investigated the potential colon cancer drug of compounds found in ginger. Dihydropyrimidine dehydrogenase was modeled using comparative homology modeling and virtual screening was performed locally on a Linux platform using AutoDock Vina®. The results showed that human dihydropyrimidine dehydrogenase is a homolog of pig dihydropyrimidine dehydrogenase. The leads of potential colon cancer drugs were beta-sitosterol, 6-Shogoal, Alloaromadedrene, and Zingiberol. They had similar binding site with levamisole for tumor necrosis factor ligand superfamily member 6 with His 148 and Tyr 192 common at their binding site whereas they had different binding sites from 5-fluorouracil for dihydropyrimidine dehydrogenase. The leads had better bioactivities compared with reference drugs (5-flourouracil and Levamisole) approved clinically for the treatment of colon cancer. In vitro, ex vivo and/or in vivo validations of the leads against colon cancer are recommended.

Zitieren

APA

Ezebuo, F. C., Lukong, C. B., Uzochukwu, I. C., & Okafor, I. N. (2016). In silico investigations revealed four potential colon cancer drugs from phytochemicals in Zingiber officinale. International Journal of Phytomedicine. https://doi.org/10.5138/09750185.1886

Vancouver

Ezebuo FC, Lukong CB, Uzochukwu IC, Okafor IN. In silico investigations revealed four potential colon cancer drugs from phytochemicals in Zingiber officinale. International Journal of Phytomedicine. 2016. doi:10.5138/09750185.1886

BibTeX
@article{Ezebuo2016,
  author = {Ezebuo, Fortunatus Chidolue and Lukong, Colin B and Uzochukwu, Ikemefuna C and Okafor, Irene N},
  title = {In silico investigations revealed four potential colon cancer drugs from phytochemicals in Zingiber officinale},
  journal = {International Journal of Phytomedicine},
  year = {2016},
  doi = {10.5138/09750185.1886}
}
Kostenlos starten →